ValiRx plc

Default features description for sign up page.

Collaborative Pipeline

Careers

Board & Management Team

Privacy Policy

How we work

Strategy & Vision

Updates

Analyst Research

AIM Rule 26

Share Price Information

Reports, AGMs & Presentations

Regulatory News

Webinars

Partnering & Useful Links

Therapeutic Areas

Inaphaea Biolabs

Evaluation Pipeline

Our Pipeline

Home

Contact Us

DM Sans

We are pleased to confirm an agreement with Italian biobanking service provider BioRep (https://www.biorep.it/en/) to provide Inaphaea's high throughput drug screening services and patient derived cells to BioRep's network of clients.

The agreement with BioRep expands our reach into Europe whilst providing backup storage and molecular biology services.

Mark Eccleston, Director of Inaphaea BioLabs comments: "BioRep is an excellent partner as we look to offer our PDC product line into European markets. Their expertise in sample management, characterisation capabilities and access to a broad client base as well as logistics are a great fit for Inaphaea."

Find out more about the agreement from the RNS here

ValiRx plc - Co-Marketing Agreement Signed with BioRep